If you are really a shareholder you will know that the 4 trials are scheduled to cost approx $3mn. 90% of this money has been put up by Cannvalate and the other 10% is easily affordable by IHL. So there is no reason for the IHL to pursue shoddy trials to save money just to promote some newsflow as you claim.
You seem to be intent on spreading false innuendo and arguing with other HC posters which is quite an achievement for someone with only 3 posts on the HC site.
Luckily there is an ignore option on HC
EB
IHL Price at posting:
8.7¢ Sentiment: Buy Disclosure: Held